The association between protease inhibitors and anal cancer outcomes in veterans living with HIV treated with definitive chemoradiation: a retrospective study

BACKGROUND: The incidence of anal squamous cell carcinoma has been increasing, particularly in people living with HIV (PLWH). There is concern that radiosensitizing drugs, such as protease inhibitors, commonly used in the management of HIV, may increase toxicities in patients undergoing chemoradiati...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoder, Alison K., Lakomy, David S., Dong, Yongquan, Raychaudhury, Suchismita, Royse, Kathryn, Hartman, Christine, Richardson, Peter, White, Donna L., Kramer, Jennifer R., Lin, Lilie L., Chiao, Elizabeth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256603/
https://www.ncbi.nlm.nih.gov/pubmed/34225709
http://dx.doi.org/10.1186/s12885-021-08514-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8256603/
https://www.ncbi.nlm.nih.gov/pubmed/34225709
http://dx.doi.org/10.1186/s12885-021-08514-z

Ejemplares similares